Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity

about

Hematologic toxicity in anal cancer patients during combined chemo-radiation: a radiation oncologist perspective.Quantifying target-specific motion in anal cancer patients treated with intensity modulated radiotherapy (IMRT).

P2860

Q30235359-189F6380-8750-412C-8469-F4B9184DDEEF Q37401422-FE8FAA7C-05E1-4D26-89AA-941A72F42656

P2860

Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity

Item

http://www.wikidata.org/entity/Q36105656

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Intensified intensity-modulate ...... h prevalent HPV p16 positivity

@ast

Intensified intensity-modulate ...... h prevalent HPV p16 positivity

@en

type

Item

label

Intensified intensity-modulate ...... h prevalent HPV p16 positivity

@ast

Intensified intensity-modulate ...... h prevalent HPV p16 positivity

@en

prefLabel

Intensified intensity-modulate ...... h prevalent HPV p16 positivity

@ast

Intensified intensity-modulate ...... h prevalent HPV p16 positivity

@en

P1476

Intensified intensity-modulate ...... h prevalent HPV p16 positivity

@en

P2093

Almalina Bacigalupo

http://www.w3.org/2001/XMLSchema#string

Dario Agnese

http://www.w3.org/2001/XMLSchema#string

Fabio Gallo

http://www.w3.org/2001/XMLSchema#string

Giuseppe Fornarini

http://www.w3.org/2001/XMLSchema#string

Liliana Belgioia

http://www.w3.org/2001/XMLSchema#string

Roberto Murialdo

http://www.w3.org/2001/XMLSchema#string

Silvana Chiara

http://www.w3.org/2001/XMLSchema#string

Stefania Garelli

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2013

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin.

US intergroup anal carcinoma trial: tumor diameter predicts for colostomy.

Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis.

Efficacy and toxicity of chemoradiation in patients with anal cancer--a retrospective analysis.

Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy.

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I).

RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute morbidity in carcinoma of the anal canal

Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy

Clinical experience of SIB-IMRT in anal cancer and selective literature review.

P304

10688-10696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V21.I37.10688

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Stefano Vagge

Renzo Corvo

P577

2015-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282430686

http://www.w3.org/2001/XMLSchema#string

P698

26457030

http://www.w3.org/2001/XMLSchema#string

P932

4588092

http://www.w3.org/2001/XMLSchema#string

Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity

about

P2860

P2860

Intensified intensity-modulated radiotherapy in anal cancer with prevalent HPV p16 positivity

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P932